Table 1

Prevalence of joint involvement and RF after the initial episode

Clinical findingGroup1-150No of positive cases/no of total cases
Initial episode4 months after6 years after
Joint painB19 negative52/52 (100)4/52 (7.7)** 2/52 (3.6)**
Joint painB19 positive12/12 (100)4/12 (33.3)** 4/12 (33.3)**
Positive RFB19 negative3/52 (5.8)3/52 (5.8)** 3/52 (5.8)**
Positive RFB19 positive1/12 (8.3)5/12 (41.6)** 4/12 (33.3)**
  • 1-150 Each group was divided into two groups based on the evidence of 1gM anti-B19 antibody at beginning of the study. **p<0.01.